Background Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is ordinarily
indicated for those with three or fewer nodules, none of which exceeds 3 cm in diameter …

BACKGROUND & AIMS:: Differences in efficacy of radiofrequency ablation (RFA) and
surgical resection (SR) are not clear for patients with hepatocellular carcinoma (HCC) …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …

AIM To evaluate whether pathologically early hepatocellular carcinoma (HCC) exhibited
local tumor progression after radiofrequency ablation (RFA) less often than typical HCC …

Introduction: Some local ablative therapies are known to be effective and safe to treat small
hepatocellular carcinomas (HCCs) and of them, radiofrequency ablation (RFA) has been …

Background and aims So far, no randomized trial or meta-analysis has been conducted on
overall survival (OS) and recurrence-free survival (RFS) factors in patients treated with …

Background There is no clear consensus on the better therapy [radiofrequency ablation
(RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for …

Abstract Background and Aim: To evaluate the evidence comparing radiofrequency ablation
(RFA) and surgical resection (RES) on the treatment of hepatocellular carcinoma (HCC) …

Radiofrequency ablation (RFA) is one of the curative treatment modalities for small
(diameter,≤ 3 cm) or early stage (single tumor≤ 5 cm in diameter or up to three tumors of≤ …

PURPOSE: To evaluate local therapeutic efficacy of radiofrequency (RF) ablation after
chemoembolization for hepatocellular carcinoma (HCC) based on tumor size and …